November 30, 20 - 9:38 am - LABS

U.S Novavax sees start of COVID-19 vaccine trial in coming weeks in Mexico

U.S pharmaceutical firm Novavax said on Monday that it has pushed back the start of late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks, reported Reuters. Novavax plans to use vaccine material produced at commercial scale for the trial in the United States and Mexico.

It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled the Phase 3 trial after first flagging an October start, hampered by issues in scaling up its manufacturing.

It also has previously said that the UK trial could be the basis for some global regulatory approvals.